GAPL (Green Air Pharma Logistics) – focus on Green Lane

Project purpose

The first Green Air Pharma Logistics (GAPL) project focuses on the  Green Lane, with the purpose of developing a set of standards and measurements to qualify and quantify a green air lane in the life science and medtech supply chain industry. 

Project objective(s)

Pharma.Aero launched a series of projects on environmental sustainability in the life sciences and medtech logistics industry. The first project of the Green Air Pharma Logistics (GAPL) series focuses on defining a green lane to support pharma manufacturers, shippers, and freight forwarders in their sustainability consideration during the lane assessment process and towards their Scope 3 decarbonisation targets. Also, the project comes as an important support for air cargo stakeholders in pursuing green air logistics initiatives as part of their Scope 1 decarbonization efforts.  

Pharma.Aero engages its global network of value chain stakeholders (shippers, airports, cargo handlers, airlines, solution providers, regulators etc.) to actively participate in all phases of the project.   

The conclusion of this project would open up new areas for further pursuits.  


Project status and key-takeaways

The project consists of 3 Work Packages:

Work Package 1 – Baselining and Setting up the Industry Problem Statement (April – September 2023):

  • Desk research 
  • Series of interviews with pharma manufacturers, airlines, and freight forwarders to gain deeper insights into their business practices and sustainability considerations (21 interviews: 7 pharmaceutical manufacturers, 6 freight forwarders and 8 airlines)
  • Interim Report providing context and delving into the key findings and takeaways of the interviews
  • Workshop: based on the interim report, engaging stakeholders participating in the Pharma Logistics Masterclass to help define the qualitative and quantitative measurements, as well as standards, of a Green Air Pharma Lane (Day 5 of the PLMC in Singapore)

Work Package 2 – Defining Green Air Pharma Corridor (October – November 2023):

  • Definition of a ‘Green Lane’ 
  • Identify the standards, measurement and evaluation criteria to quantify and qualify a green lane  
  • Identify potential partners (third-party organisations and institutions) in areas including but not restricted to emissions measurement

Work Package 3 – Publications (December 2023 – March 2024): publish Technical Report and White Paper, identify spin-off projects.

Project support and collaboration

  • Pharma.Aero Board liaison: Brussels Airport
  • Project lead: Changi Airport Group
  • Project interviewees: Bayer, GSK, MSD, Novartis, Pfizer, Roche, Zoetis, Expeditors, Geodis, JAS, Kuehne+Nagel, PSA BDP, Rhenus Logistics, Air Canada, ANA Cargo, Cathay Pacific, Etihad, Lufthansa Cargo, Qatar Airways, Singapore Airlines, Turkish Cargo.
  • Project manager: Céline Crahay, 3CeL (external consultant)

View White Paper Interested? See all of our Projects
My cart
Your cart is empty.

Looks like you haven't made a choice yet.

My cart
Your cart is empty.

Looks like you haven't made a choice yet.